Monday, March 02, 2026

14 days
RFK appoints two new members to CDC vaccine advisory panel ahead of meeting (9)
14 days
Family denied respite care as desperate parents plead for help (5)
14 days
Rezatapopt shows proof-of-concept reactivating mutant p53 in patients (9)
14 days
Novartis closes Avidity deal; Atrium Therapeutics spinout launches (2)


In Detail Full day, Monday, March 02, 2026, Timezone: America/Chicago

RFK Jr. names 2 new members to CDC vaccine panel / Beckers

Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease

Doctors Warn of a Deadly Complication From Measles Outbreaks

3 days / kffhealthnews / Rae Ellen Bichell

HHS strikes deal with 53 medical schools to expand nutrition training

11 days / beckershospitalreview / Erica Cerutti

Dozens of medical schools meet RFK Jr.'s call for greater nutrition education

11 days / fiercehealthcare

Minnesota sues feds over nearly $244M in frozen Medicaid funds

12 days / beckershospitalreview / Elizabeth Casolo

In South Carolina Measles Outbreak, Vaccine Skepticism Led to Largest Outbreak Since 2000

13 days / nytimes / Anemona Hartocollis and Kaoly Gutierrez

U.S. tops 1,100 measles cases this year as outbreaks grow

14 days / medicalxpress

Two more members added to ACIP ahead of March meeting

14 days / endpoints / Max Bayer

Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting

14 days / fiercehealthcare

RFK Jr. names 2 new members to CDC vaccine panel

14 days / beckershospitalreview / Erica Cerutti

Monday, March 2, 2026, 3:24 pm / permalink 20024 / 9 stories in 14 days


Parents of gravely ill child refused respite care / BBC

bbc - Birmingham Children's Trust refused respite help and suggested training grandparents to help.

#healthcare #publichealth #governmentpolicy #behavioralhealth

'Moment of reckoning' needed in social care, says Louise Casey

11 days / bbc

Trying to get social care can be 'horrendous', Baroness Casey tells BBC

11 days / bbc

Families Defend Disability Services Amid Medicaid Cuts

14 days / kffhealthnews / Bram Sable-Smith

E-biking boosts health, physical activity levels, study finds

17 days / medicalxpress

Parents of gravely ill child refused respite care

17 days / bbc

Monday, March 2, 2026, 2:22 am / permalink 19974 / 5 stories in 14 days


Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours / ESMO

esmo - Findings from the PYNNACLE study

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Mohamed Emam Sobeih Explores Rezatapopt Activity in TP53 Y220C-Mutated Solid Tumors

3 days / oncodaily

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

13 days / oncodaily

Targeting the untargetable cancer—rezatapopt, an oral p53 reactivator

14 days / medicalxpress

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours

14 days / esmo

Jayastu Senapati: Trial of Rezatapopt in TP53-Y220C Mutated MDS/AML

15 days / oncodaily

Rashid Lui: First-in-Class Oral Selective p53 Reactivator Looks Promising

17 days / oncodaily

Xin Lu on Targeting Mutant p53 in Solid Tumors with Rezatapopt – NEJM Group

17 days / oncodaily

Florent Peyraud: Restoring Function to a Variant of p53 in Solid Tumors

17 days / oncodaily

Aydah AlAwadhi: Targeting the “Undruggable” p53 – A Long Awaited Proof of Principle

17 days / oncodaily

Monday, March 2, 2026, 2:22 am / permalink 19973 / 9 stories in 14 days


Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance

Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions

15 days / medcitynews / Frank Vinluan

Novartis closes Avidity deal as rare heart disease spinout launches

17 days / endpoints / Lei Lei Wu

Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 14 days


StackHealth Time Machine



Outgoing Stories

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours

AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours


More StackHealth

Bluesky:


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.